Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06869109

Serum CXCL10 and CRP Levels in Patients With Acne Vulgaris in Correlation With Disease Severity

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
88 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
12 Years – 40 Years
Healthy volunteers
Accepted

Summary

the correlations between CXCL10 levels, CRP, and acne severity scores (e.g., Global Acne Grading System) suggest that CXCL10 could serve as a biomarker of inflammation and acne severity. Understanding the relationship between CXCL10, CRP, and acne severity may offer insights into novel therapeutic strategies targeting inflammatory pathways in acne.

Detailed description

Cross-sectional Observational Study. using 4 groups a 3 of different acne severity and controle one . the serum cxcl10 and crp will measured in each patient to correlate with disease severity

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTserum cxcl10serum blood sample to measure the cxcl10
DIAGNOSTIC_TESTserum crpblood sample to measure crp

Timeline

Start date
2025-03-10
Primary completion
2026-03-10
Completion
2026-04-10
First posted
2025-03-11
Last updated
2025-03-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06869109. Inclusion in this directory is not an endorsement.

Serum CXCL10 and CRP Levels in Patients With Acne Vulgaris in Correlation With Disease Severity (NCT06869109) · Clinical Trials Directory